AU613386B2 - Preparation of a new diosmine derivative - Google Patents

Preparation of a new diosmine derivative

Info

Publication number
AU613386B2
AU613386B2 AU20128/88A AU2012888A AU613386B2 AU 613386 B2 AU613386 B2 AU 613386B2 AU 20128/88 A AU20128/88 A AU 20128/88A AU 2012888 A AU2012888 A AU 2012888A AU 613386 B2 AU613386 B2 AU 613386B2
Authority
AU
Australia
Prior art keywords
diosmine
preparation
derivative
new
aluminium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU20128/88A
Other versions
AU2012888A (en
Inventor
Ramon Mosquera Pestana
Aurelio Orjales Venero
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Faes Farma SA
Original Assignee
Fabrica Espanola de Productos Quimicos y Farmaceuticos FAES SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ES8702270A external-priority patent/ES2004465A6/en
Application filed by Fabrica Espanola de Productos Quimicos y Farmaceuticos FAES SA filed Critical Fabrica Espanola de Productos Quimicos y Farmaceuticos FAES SA
Publication of AU2012888A publication Critical patent/AU2012888A/en
Application granted granted Critical
Publication of AU613386B2 publication Critical patent/AU613386B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06Benzopyran radicals
    • C07H17/065Benzo[b]pyrans
    • C07H17/07Benzo[b]pyran-4-ones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

6 13 38 8,.
COMMONWEALTH OF AUSTRALIA PATENTS ACT 1952-62 COMPLETE SPECIFICATION
(ORIGINAL)
FOR OFFICE USE: Appliz-ation Number: Lodged: Complete Specification Lodged: Accepted: Published: Priority: R la'ed Art: Class Int. Class Name of 'Applicant: Address of Applicant: Actual Inventor: Address for Service: TO BE COMPLETED BY APPLICANT FABRICA ESPAROLA DE PRODUCTOS QUIMICOS Y FARMACEUTICOS, S.A.
Lejona-Lamiaco (Vizcaya/Spain) Apartado 555 Bilbao Aurelio Orjales VENERO and Ramon Mosquera PESTANA care of R.K. MADDERN ASSOCIATES, 345 King William Street, Adelaide, South Australia, 5000 Complete Specification for the invention entitled: "PREPARATION OF A NEW DIOSMINE DERIVATIVE" The following statement is a full description of this invention, including the best method of performing it known toxwac us.
la PREPARATION OF A NEW DIOSMINE DERIVATIVE Diosmine is a polyhydroxylated flavone with eight hydroxyl groups, two of them are phenolic and the other six being in the sugar rest, and is able to undergo different reactions being esterification one of them.
Diosmine can give esters when it is treated with a reactive derivative of organic and inorganic acids in a suitable solvent. In particular Diosmine forms esters from sulfuric acid when it reacts with a sulfating agent, varying the esterification index with the conditions of the reactions, especially with the molar ratio of diosmine/sulfating agent. In certain conditions it is 'possible to esterify all the hydroxyl groups of the molecule and to afford the octasulfate of diosmine.
The sulfur trioxide-pyridine complex or the sulfur trioxide-trialkylamine complexes are used as sulfating i agents. The first of these is obtained from chlorosulfonic acid or from the sulfur trioxide and the pyridine, and it can be prepared and purified previous to its use or formed i in situ in the reaction vessel. The sulfur trioxide-pyridine i 20. complex sulfates substances such as hydrazine, diethylamine, phenol and naphthalene, and it has been used in preparation of carbohydrate, sterol and phenol sulfate esters. The sulfur trioxide-trialkylamine complexes, especially those formed with trimethylamine and triethylamine, are also useful to carry out the reaction. They are mild agents, sulfating alcohols or phenols.
In the present invention, the preparation of a new diosmine derivative is described. The diosmine derivative is an aluminium a-ddiosmine octasulfate which has a great pharmacological interest.
The product administered orally in doses of 200 mg/kg to rats with gastric lesions induced by pure ethanol (following 'the technique of A. Robert et al., Gastroenterology, 77, 433-443 (1979)) significantly protected the gastric mucosa.
2 In another experiment carried out in accordance with Shay et al's method (Gastroenterology, 5, 43-61 (1945)) the aluminium ae.
4 diosmine octasulfate significantly protected the glandular and aglandular region of the stomach at doses of 100 and 200 mg/kg., when it was administered orally immediately after the pilorus ligation.
Besides the gastric mucosa protective activity and acid-consuming capacity of the aluminium and diosmine octasulfate, it lacks of undesirable side effects.
o2 10. The preparation of the aluminium aft4\ diosmine octasulfate is carried out by the reaction of the diosmine with the sulfur trioxide-pyridine complex or with the sulfur trioxide-trialkylamine complexes, using the sulfating agents in an excess.
15. The solvent employed in the sulfation of Diosmine is chosen among pyridine, dimethylformamide and dimethylacetamide and the temperature at which the reaction oo° takes places can oscilate between 402 and 1100 C without o°~to a substantial variation in the result of the process, but at low temperatures the completion of the reaction a 00 takes more time.
The aluminium salt of the diosmine octasulfate can be made from the corresponding sodium salt or from the o corresponding ammonium salt by adding aluminium 25.hydroxychloride in an aqueous solution.
The followi.ng examples of the preparation of the So,\t. o- 'C-v-EL aluminium a~44ddiosmine octasulfate illustrate the invention but are not exhaustive.
1 A mixture of 10 g. of diosmine and 25 g. of the sulfur trioxide-pyridine complex in 100 ml. of pyridine is heated at a temperature of 60Q C for 5 hours with The upper layer of pyridine is separated by i V(ri^ CI- 3 decantation and the lower one is neutralized with concentrated aqueous sodium hydroxide. Ethyl alcohol is added dropwise until a precipitate begins to form. This deposit is filtered off and more ethyl alcohol is added to the liquid part. The new solid formed is separated by filtration and is washed several times with ethyl alcohol.
It is dried at room temperature in vus (16.7 It is p dissolved in 200 ml. of distilled water and 130 ml. of a i 15% solution of aluminium hydroxychloride is added. The 10.resulting yellow solid is filtered, washed several times OB« with water and is dried in vacuum at room temperature c 0 o (26 M.P. higher than 250QC.
S IR (3490, 1640 cm C28H64Al 6 0 7 9
S
8 calculated: Al 18,34 S 10,90 o 15. found 18,71 10,81 0 00 l* EXAMPLE 2 00 g. of diosmine and 24 g. of the sulfur complex is heated in 40 ml. of a dimethylformamide for 2 hours at a temperature of The mixture is cooled at room temperature and then poured into 400 ml. of acetone with stirring. The upper layer is separated by decantation and the lower layer is washed twice acetone. It is the dissolved in water and 150 ml. of a 15% solution of aluminium hydroxychloride is added. The solid which forms is filtered, washed in water and dried.
17 g. of the product described in Example 1. are obtained.
L, I~ ~I _ii~ U-YI_-~L -I
AU20128/88A 1987-07-31 1988-07-29 Preparation of a new diosmine derivative Ceased AU613386B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
ES8702270A ES2004465A6 (en) 1986-05-09 1987-07-31 Preparation of a new diosmine derivate.
EP87500053A EP0302155B1 (en) 1986-05-09 1987-07-31 Preparation of a new diosmine derivate
ES8702270 1987-07-31
EP87500053 1987-07-31

Publications (2)

Publication Number Publication Date
AU2012888A AU2012888A (en) 1989-02-02
AU613386B2 true AU613386B2 (en) 1991-08-01

Family

ID=26112482

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20128/88A Ceased AU613386B2 (en) 1987-07-31 1988-07-29 Preparation of a new diosmine derivative

Country Status (8)

Country Link
JP (1) JPS6463590A (en)
AR (1) AR247216A1 (en)
AT (1) AT397504B (en)
AU (1) AU613386B2 (en)
CA (1) CA1318317C (en)
FI (1) FI88924C (en)
GR (1) GR880100499A (en)
NO (1) NO171165C (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3730858B2 (en) * 2000-12-01 2006-01-05 株式会社エヌ・ティ・ティ・ドコモ Mail system, server, and mail transmission / reception device

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6967M (en) * 1968-01-22 1969-05-19
EP0075626A1 (en) * 1981-09-29 1983-04-06 American Cyanamid Company Novel rutin nona- and deca(H-)sulfate salts, methods of preparing novel salts, and use of novel salts of complement inhibitors

Also Published As

Publication number Publication date
AR247216A1 (en) 1994-11-30
FI88924C (en) 1993-07-26
AU2012888A (en) 1989-02-02
FI883508A0 (en) 1988-07-26
JPS6463590A (en) 1989-03-09
NO171165B (en) 1992-10-26
ATA185388A (en) 1993-09-15
FI883508A (en) 1989-02-01
AT397504B (en) 1994-04-25
FI88924B (en) 1993-04-15
NO171165C (en) 1993-02-03
NO883363L (en) 1989-02-01
CA1318317C (en) 1993-05-25
NO883363D0 (en) 1988-07-29
JPH0555518B2 (en) 1993-08-17
GR880100499A (en) 1989-04-12

Similar Documents

Publication Publication Date Title
DK175970B1 (en) Process for organic synthesis of oligosaccharides containing galactosamine uronic acid patterns, obtained by the process, oligosaccharides and biological use of such oligosaccharides
US5190947A (en) Codeine salt of a substituted carboxylic acid, its use and pharmaceutical compositions thereof
JPS59163400A (en) Sodium salt of ulsodeoxycholic acid sulfate ester
US3279990A (en) Carbohydrate esters of salicylic acid, their production and administration
US4894449A (en) Diosmin octakis (hydrogen sulfate) aluminum complex
US4221907A (en) Substituted O-α-D and O-β-D-multi-galactopyranosyl and glucopyranosyl 1→4 and 1→6 galactopyranosyl 1→6 α-D-glucopyranoses
AU613386B2 (en) Preparation of a new diosmine derivative
SK194892A3 (en) Method of production of diacetylreine
HU205132B (en) Process for producing fluorine-substituted epipodophyllotoxin glycosides and pharmaceutical compositions comprising same as active ingredient
EP0251039B1 (en) Esters of salsalate with guaiacol, for treating phlogistic bronchopneumopathies
US3953423A (en) Preparation of a new flavanone derivative
US4232150A (en) Oligosaccharide precursors to substituted O-α-D and O-β-D-multigalactopyranosyl and glucopyranosyl 1→4 and 1→6 galactopyranosyl 1→6α-D-glucopyranoses
US4404365A (en) Modulators of the complement system
US4374832A (en) Modulators of the complement system comprising polyhexaose arylene sulfate derivatives
CA1139749A (en) Rutin poly(h-)sulfate salts and related compounds
CA1061777A (en) Terpenes
US4103025A (en) Novel terpenes
EP0558435B1 (en) Sulfated diosmin derivative
KR100199066B1 (en) New salts derived from dialkylaminoalkylsulphonyl-26 pristinamycin iib
EP0420232A2 (en) Water soluble derivatives of glycoside bioflavonoids, processes for their preparation and related pharmaceutical compositions
DE3787969T2 (en) Preparation of a diosmin derivative.
US4459293A (en) Method of modulating the complement system by administering bis-[β-D-glucopyranosyl-1-thio (or sulfinyl or sulfonyl)]-aryline sulfate derivatives and the cation salts thereof
US4596894A (en) Mixture of diasteroisomer compounds, as obtained from (-)-5-(1-hydroxy-1-methylethyl)-2-methyl-2-cyclohexene-1-one, having mucosecretolytic activity, a process for its preparation and pharmaceutical compositions containing the same
Salim Protection against chronic gastric ulceration in the rat with sulfhydryl‐containing agents
KR0155230B1 (en) Propylglycolmannuronate sodium sulfate active on the ischemic brain and cardiovascular system, process for their preparation